VIRIDIAN THERAPEUTICS INC (VRDN) Stock Analyst Earnings Estimates
NASDAQ:VRDN - Nasdaq - US92790C1045 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.96M 181.90% | 1.77M -40.20% | 314K -82.26% | 322.004K 2.55% | 235.304K -26.93% | 39.849M 16,835.13% | 337.66M 747.35% | 680.55M 101.55% | 1.071B 57.37% | 1.372B 28.10% | 1.655B 20.63% | 1.413B -14.62% | |
| EBITDA YoY % growth | -79.61M -99.12% | -134.04M -68.37% | -253.928M -89.44% | -255.472M -0.61% | -297.761M -16.55% | -336.102M -12.88% | 397.4M 218.24% | 964M 142.58% | 1.192B 23.65% | 1.451B 21.73% | 1.747B 20.40% | N/A | |
| EBIT YoY % growth | -79.73M -98.23% | -134.3M -68.44% | -254.45M -89.46% | -297.921M -17.08% | -360.466M -20.99% | -378.983M -5.14% | -141.272M 62.72% | 110.86M 178.47% | 473.14M 326.79% | 731.74M 54.66% | 966.59M 32.09% | 873.72M -9.61% | |
| Operating Margin | -2,693.58% | -7,587.57% | -81,035.03% | -92,520.85% | -153,191.73% | -951.05% | -41.84% | 16.29% | 44.18% | 53.33% | 58.40% | 61.83% | |
| EPS YoY % growth | -7.69 32.01% | -4.03 47.59% | -5.32 -32.01% | -4.06 23.59% | -4.28 -5.30% | -4.02 6.04% | -2.11 47.46% | 0.27 112.89% | 3.54 1,198.39% | 5.82 64.59% | 7.03 20.83% | 7.61 8.22% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.05 21.90% | -1.01 -28.30% | -1.05 -2.77% | -1.04 9.96% | -1.09 -3.14% | -1.19 -17.75% | -1.23 -17.74% | -1.18 -14.27% | -0.97 10.90% |
| Revenue Q2Q % growth | 41.902K -41.80% | 51K -29.17% | 51K -29.17% | 68.003K -20.93% | 81.6K 94.74% | N/A | N/A | N/A | 26.327M 32,163.48% |
| EBITDA Q2Q % growth | -77.447M -9.15% | -79.101M -41.88% | -80.852M -12.45% | -82.792M 0.33% | -84.732M -9.41% | -98.24M -24.20% | -101.744M -25.84% | -105.465M -27.38% | -86.024M -1.52% |
| EBIT Q2Q % growth | -84.212M -17.81% | -84.5M -51.17% | -87.4M -21.07% | -88.519M -6.04% | -96.135M -14.16% | -108.875M -28.85% | -112.697M -28.94% | -116.527M -31.64% | -97.197M -1.10% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -1.15 -5.50% | -1.08 | -0.07 | -6.60% |
| Q2 2024 Q2Q % growth | -1.02 19.69% | -0.91 | -0.11 | -12.54% |
| Q1 2024 Q2Q % growth | -0.79 50.93% | -1.13 | 0.34 | 29.83% |
| Q4 2023 Q2Q % growth | -1.35 -19.47% | -1.02 | -0.33 | -31.95% |
| Q3 2023 Q2Q % growth | -1.09 -26.74% | -1.29 | 0.20 | 15.60% |
| Q2 2023 Q2Q % growth | -1.27 -19.81% | -1.32 | 0.05 | 3.82% |
| Q1 2023 Q2Q % growth | -1.61 -64.29% | -1.04 | -0.57 | -54.81% |
| Q4 2022 Q2Q % growth | -1.13 14.39% | -0.74 | -0.39 | -52.18% |
| Q3 2022 Q2Q % growth | -0.86 31.20% | -1.04 | 0.18 | 17.11% |
| Q2 2022 Q2Q % growth | -1.06 52.04% | -0.92 | -0.14 | -14.92% |
| Q1 2022 Q2Q % growth | -0.98 66.32% | -1.10 | 0.12 | 10.71% |
| Q4 2021 Q2Q % growth | -1.32 75.14% | -0.92 | -0.40 | -44.25% |
| Q3 2021 Q2Q % growth | -1.25 16.67% | -1.50 | 0.25 | 16.82% |
| Q2 2021 Q2Q % growth | -2.21 -22.78% | -1.55 | -0.66 | -42.73% |
| Q1 2021 Q2Q % growth | -2.91 -7.78% | -0.77 | -2.14 | -277.37% |
| Q4 2020 Q2Q % growth | -5.31 -14.19% | -0.63 | -4.68 | -748.79% |
| Q3 2020 Q2Q % growth | -1.50 72.22% | -2.03 | 0.53 | 26.01% |
| Q2 2020 Q2Q % growth | -1.80 58.62% | -2.52 | 0.72 | 28.70% |
| Q1 2020 Q2Q % growth | -2.70 52.63% | -2.94 | 0.24 | 8.09% |
| Q4 2019 Q2Q % growth | -4.65 | -3.86 | -0.79 | -20.60% |
| Q3 2019 Q2Q % growth | -5.40 | -4.53 | -0.87 | -19.24% |
| Q2 2019 Q2Q % growth | -4.35 | -5.70 | 1.35 | 23.67% |
| Q1 2019 Q2Q % growth | -5.70 | -5.26 | -0.44 | -8.30% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 86K 19.44% | 46.685K | 39.315K | 84.21% |
| Q2 2024 Q2Q % growth | 72K | 87.873K | -15.873K | -18.06% |
| Q1 2024 Q2Q % growth | 72K -26.53% | 72.604K | -603.6000000000058 | -0.83% |
| Q4 2023 Q2Q % growth | 72K -34.55% | 162.792K | -90.792K | -55.77% |
| Q3 2023 Q2Q % growth | 72K -94.00% | 112.853K | -40.853K | -36.20% |
| Q2 2023 Q2Q % growth | 72K -72.31% | 220.493K | -148.493K | -67.35% |
| Q1 2023 Q2Q % growth | 98K -55.45% | 113.444K | -15.444K | -13.61% |
| Q4 2022 Q2Q % growth | 110K -47.62% | 522.118K | -412.118K | -78.93% |
| Q3 2022 Q2Q % growth | 1.2M 471.43% | 315.517K | 884.483K | 280.33% |
| Q2 2022 Q2Q % growth | 260K -76.15% | 236.344K | 23.656K | 10.01% |
| Q1 2022 Q2Q % growth | 220K -84.83% | 310.284K | -90.284K | -29.10% |
| Q4 2021 Q2Q % growth | 210K 320.00% | 291.383K | -81.383K | -27.93% |
| Q3 2021 Q2Q % growth | 210K | 463.284K | -253.284K | -54.67% |
| Q2 2021 Q2Q % growth | 1.09M 541.18% | 1.09M | % | |
| Q1 2021 Q2Q % growth | 1.45M 74.70% | 1.45M | % | |
| Q4 2020 Q2Q % growth | 50K -94.32% | 81.6K | -31.6K | -38.73% |
| Q3 2020 Q2Q % growth | -100.00% | 157.59K | -157.59K | -100.00% |
| Q2 2020 Q2Q % growth | 170K -93.23% | 532.236K | -362.236K | -68.06% |
| Q1 2020 Q2Q % growth | 830K 124.32% | 594.15K | 235.85K | 39.70% |
| Q4 2019 Q2Q % growth | 880K | 737.256K | 142.744K | 19.36% |
| Q3 2019 Q2Q % growth | 700K | 1.186M | -486K | -40.98% |
| Q2 2019 Q2Q % growth | 2.51M | 262.477K | 2.248M | 856.28% |
| Q1 2019 Q2Q % growth | 370K | 471.75K | -101.75K | -21.57% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -6.98% | 0% | -2.43% |
| Revenue | 0% | -51.14% | 0% | 11.89% |